相关实验视频

Updated: Jun 23, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

血代谢物和神经退行性疾病之间的因果关系

Ao Zhang¹, Congcong Pan¹, Meifen Wu²

¹Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan City, Guangdong Province, China.

Progress in neuro-psychopharmacology & biological psychiatry

|June 22, 2024

概括

这项研究使用了门德尔的随机化来确定血代谢物和神经退行性疾病 (如阿尔茨海默病和帕金森病) 之间的因果关系. 三种关键代谢物可以作为两种条件的共同生物标志物.

科学领域:

基因组学和代谢学
神经退行性疾病研究研究
生物标志物发现发现

背景情况:

观察性研究在确定代谢生物标志物与神经退行性疾病 (如阿尔茨海默病 (AD) 和帕金森病 (PD)) 之间的因果关系方面面临挑战.
了解这些因果关系对于开发有效的诊断和治疗策略至关重要.

研究的目的:

通过使用孟德尔随机化 (MR) 方法,研究血代谢物和神经退行性疾病之间的因果关系.
确定潜在的代谢生物标志物和AD和PD的治疗点.

主要方法:

利用基因关联与1400个血代谢特征作为暴露.
采用大规模的全基因组关联研究 (GWAS) 对AD和PD的总结统计数据.
应用逆方差加权 (IVW) 分析和对已识别的代谢物进行缩途径分析.

主要成果:

在发现数据集中确定了69种可能与AD相关的代谢物和47种与PD相关的代谢物.
验证了AD的4个代谢物和PD的1个代谢物,有三个常见的潜在标记物:三 betaine,palmitoleoylcarnitine (C16:1) 和X-23655.
路径丰富分析强调了SLC介导的跨膜运输路径作为潜在的干预目标.

结论:

这项研究通过整合基因组学和代谢学,为血代谢物对神经退行性疾病的因果作用提供了新的见解.
已识别的代谢物和代谢途径为AD和PD的潜在生物机制提供了更深入的理解.
这些发现为未来治疗AD和PD的治疗干预提供了有希望的目标.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.门德尔的随机化帕金森病是帕金森病的一种.血代谢产物中的代谢产物

更多相关视频

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.